TG Therapeutics (TGTX) News Today $39.82 +2.07 (+5.48%) Closing price 04:00 PM EasternExtended Trading$38.38 -1.45 (-3.63%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period TG Therapeutics rises after trial setback for high dose version of Roche’s MS drugApril 2 at 5:19 PM | msn.comClearbridge Investments LLC Acquires Shares of 1,835,127 TG Therapeutics, Inc. (NASDAQ:TGTX)Clearbridge Investments LLC bought a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,835,127 shares of the biophApril 2 at 5:14 AM | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by Prudential Financial Inc.Prudential Financial Inc. lowered its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 44.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 168,575 shares of the biopharmaceuticApril 2 at 3:57 AM | marketbeat.comKLP Kapitalforvaltning AS Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)KLP Kapitalforvaltning AS bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 30,700 shares of the biopharmaceutical company's stock, valued atApril 2 at 3:49 AM | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Receives $40.67 Average Price Target from AnalystsApril 2 at 1:51 AM | americanbankingnews.comPictet Asset Management Holding SA Trims Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Pictet Asset Management Holding SA reduced its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 22.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,793,931 shares of the biopharmaceutical company's stock after selling 788,65March 31 at 4:54 AM | marketbeat.comTeacher Retirement System of Texas Has $1.31 Million Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Teacher Retirement System of Texas lifted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 18.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,565 shares of the biopharmaceuticaMarch 30 at 3:44 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Envestnet Portfolio Solutions Inc. bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,177 shares of the biopharmaceutical compMarch 30 at 3:27 AM | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from BrokeragesShares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have been given an average rating of "Moderate Buy" by the six ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy ratiMarch 30 at 2:19 AM | marketbeat.comSegall Bryant & Hamill LLC Acquires 27,128 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)Segall Bryant & Hamill LLC grew its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 51.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 79,518 shares of the biopharmaceutical company's stock after acquiring an additional 27,128 sMarch 29, 2025 | marketbeat.comNatixis Advisors LLC Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Natixis Advisors LLC purchased a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 28,482 shares of the biopharmaceutical company's stock, valued atMarch 27, 2025 | marketbeat.comProficio Capital Partners LLC Takes $306,000 Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Proficio Capital Partners LLC bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 10,174 shares of the biopharmaceutical company's stock, valued at approximately $306,0March 27, 2025 | marketbeat.comCorient Private Wealth LLC Sells 35,309 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)Corient Private Wealth LLC trimmed its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 47,378 shares of the biopharmaceutical company's stock after selling 35March 26, 2025 | marketbeat.comAdvantage Alpha Capital Partners LP Sells 8,932 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)Advantage Alpha Capital Partners LP trimmed its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 39.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,447 shares of the bioMarch 25, 2025 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Sets New 52-Week High - Here's WhyTG Therapeutics (NASDAQ:TGTX) Reaches New 1-Year High - Time to Buy?March 25, 2025 | marketbeat.comSimplify Asset Management Inc. Acquires Shares of 11,237 TG Therapeutics, Inc. (NASDAQ:TGTX)Simplify Asset Management Inc. bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 11,237 shares of the biopharmaceutical company's stock, valued at approximately $338,000March 24, 2025 | marketbeat.comCibc World Markets Corp Acquires Shares of 13,065 TG Therapeutics, Inc. (NASDAQ:TGTX)Cibc World Markets Corp bought a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 13,065 shares of the biopharmaceutical companMarch 24, 2025 | marketbeat.comHillsdale Investment Management Inc. Invests $4.52 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)Hillsdale Investment Management Inc. purchased a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 150,200 shares of the biopharmaceutical companyMarch 23, 2025 | marketbeat.comCommonwealth Equity Services LLC Decreases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Commonwealth Equity Services LLC lessened its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 4.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,112 shares of the biophaMarch 23, 2025 | marketbeat.comThese Insurance Stocks And Biotech Leader Hit New Highs As Stock Market CrumblesMarch 21, 2025 | investors.comTG Therapeutics (NASDAQ:TGTX) Sets New 1-Year High - Still a Buy?TG Therapeutics (NASDAQ:TGTX) Reaches New 1-Year High - Here's WhyMarch 20, 2025 | marketbeat.comTG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to AnalystsMarch 19, 2025 | msn.comRaymond James Financial Inc. Invests $14.51 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)Raymond James Financial Inc. purchased a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 481,989 shares of the biopharmaceutical company's stockMarch 19, 2025 | marketbeat.comVictory Capital Management Inc. Raises Stock Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Victory Capital Management Inc. increased its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 65.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,034 shares of the biophMarch 19, 2025 | marketbeat.comGWN Securities Inc. Acquires Shares of 13,127 TG Therapeutics, Inc. (NASDAQ:TGTX)GWN Securities Inc. acquired a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 13,127 shares of the biopharmaceutical company's stock,March 17, 2025 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 7.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,269,513 shares of the biopharmaceutical company's stock after acquiring an additionMarch 16, 2025 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Trading Up 9.5% - Should You Buy?TG Therapeutics (NASDAQ:TGTX) Trading Up 9.5% - Here's WhyMarch 15, 2025 | marketbeat.comIs TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?March 14, 2025 | msn.comTG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming TrialsMarch 14, 2025 | seekingalpha.comTG Therapeutics: Exciting Briumvi Performance, Looking To Re-EnterMarch 12, 2025 | seekingalpha.comProficio Capital Partners LLC Buys Shares of 10,174 TG Therapeutics, Inc. (NASDAQ:TGTX)Proficio Capital Partners LLC bought a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,174 shares of the biopharmaceutical company's stock, valued at approximMarch 12, 2025 | marketbeat.comBiotech Stock TG Therapeutics Hits A High In Market MeltdownMarch 11, 2025 | msn.comTG Therapeutics (NASDAQ:TGTX) Sets New 52-Week High - What's Next?TG Therapeutics (NASDAQ:TGTX) Reaches New 12-Month High - Here's WhyMarch 11, 2025 | marketbeat.comEdgestream Partners L.P. Buys Shares of 53,738 TG Therapeutics, Inc. (NASDAQ:TGTX)Edgestream Partners L.P. bought a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 53,738 shares of the biopharmaceutical company's stock, valued at approximately $1,618,000. OMarch 11, 2025 | marketbeat.comTG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income TurnaroundMarch 10, 2025 | finance.yahoo.comInceptionr LLC Makes New $263,000 Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)Inceptionr LLC acquired a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 8,722 shares of the biopharmaceutical company's stock, valued at approximatelyMarch 10, 2025 | marketbeat.comBank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Bank of New York Mellon Corp boosted its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 10.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 923,488 shares of the biopharmaceutical company's stock afterMarch 9, 2025 | marketbeat.comS&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market ShakeoutMarch 8, 2025 | investors.comQ2 Earnings Forecast for TG Therapeutics Issued By B. RileyTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Analysts at B. Riley issued their Q2 2025 earnings per share (EPS) estimates for shares of TG Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutMarch 8, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Cuts Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Jackson Creek Investment Advisors LLC lessened its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 46,127 shares of the biopharmaceuticMarch 8, 2025 | marketbeat.comWhy TG Therapeutics Stock Was Soaring This WeekMarch 7, 2025 | fool.comCantor Fitzgerald Predicts TG Therapeutics FY2025 EarningsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of TG Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biopharmaceutical companMarch 7, 2025 | marketbeat.comTG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual MeetingMarch 7, 2025 | globenewswire.comQ1 Earnings Estimate for TG Therapeutics Issued By B. RileyTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Investment analysts at B. Riley issued their Q1 2025 EPS estimates for TG Therapeutics in a research note issued on Tuesday, March 4th. B. Riley analyst M. Mamtani expects that the biopharmaceutical company will post earnings of $0.21 per shareMarch 7, 2025 | marketbeat.comHC Wainwright Comments on TG Therapeutics Q1 EarningsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of TG Therapeutics in a research report issued on Tuesday, March 4th. HC Wainwright analyst E. White expects that the biopharmaceutical company willMarch 7, 2025 | marketbeat.comFY2025 EPS Forecast for TG Therapeutics Increased by AnalystTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for shares of TG Therapeutics in a report released on Tuesday, March 4th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company willMarch 6, 2025 | marketbeat.comCookson Peirce & Co. Inc. Grows Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Cookson Peirce & Co. Inc. increased its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 61.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,081 shares of the biopharmaceutical company's stoMarch 6, 2025 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Rating Increased to Hold at StockNews.comStockNews.com upgraded shares of TG Therapeutics from a "sell" rating to a "hold" rating in a research report on Tuesday.March 5, 2025 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Trading Up 5.2% on Strong EarningsTG Therapeutics (NASDAQ:TGTX) Stock Price Up 5.2% on Earnings BeatMarch 5, 2025 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Sets New 12-Month High - Time to Buy?TG Therapeutics (NASDAQ:TGTX) Hits New 1-Year High - Time to Buy?March 5, 2025 | marketbeat.com Remove Ads Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address TGTX Media Mentions By Week TGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TGTX News Sentiment▼1.500.57▲Average Medical News Sentiment TGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TGTX Articles This Week▼126▲TGTX Articles Average Week Remove Ads Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Intra-Cellular Therapies News Genmab A/S News Dr. Reddy's Laboratories News Moderna News Viatris News Ascendis Pharma A/S News Qiagen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TGTX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TGTX Stock Free TGTX Stock Alerts